Skip to main content
Top
Published in: International Urology and Nephrology 3/2024

14-10-2023 | Urinary Incontinence | Urology - Original Paper

A modified sling mid-urethral suspension + subcutaneous tunnel-double point fixation technique for male stress urinary incontinence: a pilot study

Authors: Yingxiu Chen, Xin Song, Tingting Lv, Jin Huang, Zhikang Cai, Jiasheng Yan

Published in: International Urology and Nephrology | Issue 3/2024

Login to get access

Abstract

Objectives

The aim of this study was to demonstrate the feasibility of a modified sling mid-urethral suspension + subcutaneous tunnel-double point fixation technique for the treatment of male urinary incontinence and to preliminarily evaluate the short-term clinical efficacy of this technique.

Patients and methods

The clinical data of patients treated with the modified sling mid-urethral suspension + subcutaneous tunnel-double point fixation technique using a Pelvimesh pelvic floor repair patch as a sling were collected. The primary evaluation criteria were surgery-related indicators and daily urinal pad usage before and after treatment, and the secondary evaluation criteria were the corresponding incontinence scores and the results of surgery-related questionnaires.

Results

After 1–12 months of follow-up, seven patients were clinically cured. Follow-up 1 month after surgery showed that one patient (14.3%) used one pad daily, and six patients (85.7%) did not need pads. The incontinence quality of life questionnaire (I-QOL) scores at 3 days and 1 month postoperatively were 89.4 ± 2.5 and 88.1 ± 6.7, respectively, which were significantly higher than the preoperative scores (31.5 ± 18.9) (P < 0.05). The scores of the International Continence Control Association Incontinence Questionnaire Short Form (ICI-Q-SF) at 3 days and 1 month postoperatively were 3.2 ± 0.9 and 4.2 ± 1.7, respectively, which were significantly lower than the preoperative scores of 19.4 ± 5.0 (P < 0.05). In addition, the results of the surgery-related questionnaires were positive. No serious complications occurred in any of the patients.

Conclusion

The modified sling mid-urethral suspension + subcutaneous tunnel-double point fixation technique for the treatment of male urinary incontinence patients is safe, effective, minimally invasive, and has few complications. However, further validation in large sample, randomized, comparative, and longer-term follow-up studies is still needed.
Appendix
Available only for authorised users
Literature
4.
15.
go back to reference Grabbert M, Mumm JN, Klehr B et al (2018) Extended follow-up of the Advance XP male sling in the treatment of male urinary stress incontinence after 48 months: results of a prospective and multicenter study [J]. Neurourol Urodyn 38:1973–1978. https://doi.org/10.1002/nau.24101CrossRef Grabbert M, Mumm JN, Klehr B et al (2018) Extended follow-up of the Advance XP male sling in the treatment of male urinary stress incontinence after 48 months: results of a prospective and multicenter study [J]. Neurourol Urodyn 38:1973–1978. https://​doi.​org/​10.​1002/​nau.​24101CrossRef
22.
go back to reference Bauer RM, Grabbert MT, Klehr B et al (2017) 36-month data for the advance XP (R) male sling: results of a prospective multicenter study[J]. BJU Int 119(4):626–630CrossRefPubMed Bauer RM, Grabbert MT, Klehr B et al (2017) 36-month data for the advance XP (R) male sling: results of a prospective multicenter study[J]. BJU Int 119(4):626–630CrossRefPubMed
Metadata
Title
A modified sling mid-urethral suspension + subcutaneous tunnel-double point fixation technique for male stress urinary incontinence: a pilot study
Authors
Yingxiu Chen
Xin Song
Tingting Lv
Jin Huang
Zhikang Cai
Jiasheng Yan
Publication date
14-10-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03822-8

Other articles of this Issue 3/2024

International Urology and Nephrology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine